Civil Litigation
Aug. 15, 2017
Johnson & Johnson defense highlights genetics as causing cancer in talc trial
Two Johnson & Johnson defense witnesses in the talc liability trial Monday said the plaintiff’s genetics and lifestyle choices, not the application of talc, most likely led to developing ovarian cancer.
LOS ANGELES — Two Johnson & Johnson defense witnesses in the talc liability trial Monday said the plaintiff’s genetics and lifestyle choices, not the application of talc, most likely led to developing ovarian cancer.
Testimony by a pathologist and gynecological oncologist underscored a strategy by defense attorneys to show the jury that plaintiff Eva Echeverria developed cancer not because she chronically applied talc to her per...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In